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ABSTRAK
Bayi berat lahir rendah (BBLR) didefinisikan sebagai bayi yang lahir dengan berat <2500 gram. Penyebab 
BBLR di negara maju umumnya adalah prematuritas, sedangkan di negara berkembang sebagian besar oleh 
karena gangguan pertumbuhan intra-uterin. Konsep perkembangan penyakit pada usia dewasa khususnya 
hipertensi dan penyakit ginjal dihubungkan dengan lingkungan intrauterin, gangguan pertumbuhan intrauterin, 
kelahiran prematur dan nutrisi janin. Hipotesis “The Fetal Origin” menyatakan bahwa penyakit metabolik secara 
langsung berhubungan dengan status nutrisi yang buruk pada fase awal kehidupan. Terdapat hubungan terbalik 
antara BBLR dengan risiko kejadian hipertensi di masa mendatang. Patomekanisme  hubungan antara BBLR 
dan hipertensi bersifat multifaktorial yaitu hambatan nefrogenesis, faktor gen, hiperaktiifitas saraf simpatik, 
disfungsi endotel, defisiensi elastin, resistensi insulin dan  aktivasi sistem renin angiotensin.
Kata kunci: gangguan pertumbuhan intra-uterin, hipertensi.
ABSTRACT
Low birth weight (LBW) is defined as a birth weight of a liveborn infant of <2,500 gram. In developed 
countries, LBW is commonly caused by preterm birth; while in developing countries, it is mostly due to 
intrauterine growth retardation. The concept of developmental origins of adult diseases, particularly on late-
onset diseases such as hypertension and kidney disease, implies that there is a correlation between intrauterine 
milieu, intrauterine growth retardation, premature birth and infant feeding. The ‘fetal origin hypothesis’ suggests 
that metabolic diseases are directly related to poor nutritional status in early life.
There is an inverse association between LBW and later risk of hypertension. The pathomechanism that 
links LBW and hypertension is multifactorial including delayed nephrogenesis, genetic factors, sympathetic 
hyperactivity, endothel dysfunction, elastin deficiencies, insulin resistance and activation of renin-angiotension 
system.
Keywords: intra-uterine growth retardation, hypertension.
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INTRODUCTION
Low birth weight (LBW) is defined as a birth 
weight of a liveborn infant of <2,500 gram. In 
developed countries, LBW is commonly caused 
by preterm birth; while in developing countries, it 
is mostly due to intrauterine growth retardation. 
When it is associated with gestational age, LBW 
can be categorized into LBW that is appropriate 
for gestational age (AGA) and LBW that is 
small for getational age (SGA).1 It has been 
estimated that 8-26% of all child birth worldwide 
is LBW, in which higher prevalence is found in 
developing countries compared to the developed 
countries.2
Fetal size is affected by maternal nutritional 
intake and available uterine space on fetal 
development. Impaired fetal nutritional intake 
due to undernutrition during pregnancy, 
uterine vascular abnormalities (preeclampsia 
and cardiovascular risk factors including 
hypertension and smoking) as well as primiparity, 
hydroamnios, gemelli and low maternal  body 
size may lead to LBW.3
The concept of developmental origins of adult 
diseases, particularly on late-onset diseases such 
as hypertension and kidney disease, implies that 
there is a correlation between intrauterine milieu, 
intrauterine growth retardation, premature birth 
and infant feeding.4 A study by Barker et al.5 
indicates that intrauterine factors have roles 
on adult-onset cardiovascular and metabolic 
diseases. Various studies have also demonstrated 
the tendency of increased blood pressure in adult 
life in infants with small size at birth, small 
head circumference, small placenta size and 
disproportional birth weight to placenta size.6
FETAL PROGRAMMING
During intrauterine period, body tissues 
experience rapid cell divisions, which is called 
the critical periods. Poor nutritional supply will 
reduce the capacity for cell division.7
Low birth weight is an important indicator 
for nutritional status and fetal growth. The 
‘fetal origin hypothesis’ suggests that metabolic 
diseases are directly related to poor nutritional 
status in early life. Nutritional deprivation during 
pregnancy usually will cause low birth weight.8 
Baker et al.9 have demonstrated that impaired 
fetal growth is associated with increased 
mortality due to cardiovascular disease in later 
life.
Suboptimal intrauterine condition will cause 
fetal growth retardation and induce phenotype 
changes in consistent with the condition. Such 
adaptive process is aimed to increase the capacity 
of intrauterine life and postnatal condition. For 
example, blood supply and nutritional delivery to 
the brain remain optimal by sacrificing the blood 
flow and nutritional supply to organs considered 
less vital. However, the adaptive response may 
result in later consequences such as hypertension, 
kidney disease, insulin resistance and type-2 
diabetes mellitus, particularly in supporting 
postnatal conditions such as obesity, high salt 
intake and stress.3
PATHOMECHANISM LINK BETWEEN LBW 
AND HYPERTENSION
Blood pressure is affected by intravascular 
volume and peripheral resistance. An increase in 
one of those two factors will cause hypertension. 
The pathomechanism of  hypertension 
development in subjects with LBW has not been 
fully understood, but the available evidences 
have demonstrated that it may result from 
interactions of various factors: 
Nephrogenesis Inhibition
Experimental animal and human studies 
have demonstrated that kidney has a role on the 
correlation between maternal undernutrition 
and intrauterine programming of hypertension. 
Brenner et al.10 suggest that a reduced nephron 
number is associated with hypertension. Kidney 
structure, in this case, the nephron number, 
is the predictor of hypertension and chronic 
kidney disease incidences. In Afro-American 
population, in which has high prevalence of 
hypertension and progressive kidney disease, 
autopsy studies have found smaller kidney size 
and less number of nephron.11 Keller et al.12 has 
also demonstrated that patients with hypertension 
have smaller number of nephron than the control 
group that have normal blood pressure.
Reduced nephron number will cause 
glomerular hyperfunction. In this case, 
nephromegali, intraglomerular hypertension and 
glomerular hyperfiltration occur. In long term, the 
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process will lead to glomerulosclerosis, damage 
of nephrons and increased blood pressure. Rapid 
weight gain after birth can cause exacerbation 
of glomerular damage as the immense body 
mass will increase excretion load.12 Other 
factors assumed as the cause of nephrogenesis 
impairment in intrauterine under-nutrition are: a). 
Life history theory. It is assumed that impaired 
nephrogenesis is caused by a mechanism, 
which is known as the life history theory. 
The theory suggests that in under-nutrition 
condition, energy allocation will be prioritized 
for vital organ such as the brain by sacrificing 
the nutrition for less vital organ, in this case, 
including the kidney.12 b). The effect of maternal 
glucocorticoid on fetus. Glucocorticoid has an 
important role on fetal growth due to its effect 
on the expressions of various proteins at cellular 
and molecular levels. During pregnancy, there 
is a lower glucocorticoid level in fetus than the 
maternal level. 11b-hydrosteroiddehydrogenase 
(11b-HSD2) is an enzyme that converts active 
cortisol into inactive form. The enzyme 
expression is increased in the placenta and it 
inhibits maternal glucocorticoid entering fetal 
blood circulation. It has been demonstrated that 
there is reduced level of 11b-HSD2 enzyme in 
experimental animals with low-protein diet that 
may explain the increased glucocorticoid level in 
fetus.13 Fetal hypoxia can also reduce 11b-HSD2 
level and the activity of cystotrophoblasts. 
There are evidences that glucocorticoid causes 
organogenesis inhibition in fetus. A study with 
lambs that had received only dexamethasone 
for 2 days (day 26 and day 28 of 150 days of 
pregnancy) shows that it can cause incrased blood 
pressure starting from the 4th month afterbirth 
until the later life of those experimental animals, 
in which the autopsy study has found reduced 
nephron number as many as 40% compared 
to control.14 c). The role of angiotensin II. 
Angiotensin II (Ang-II) has been known to have 
an important role on organogenesis including the 
kidney. During the under-nutrition condition, the 
intrauterine renin-angiotensin (RA) system is 
suppressed.  A study shows that there is reduced 
expression of rennin gene with protein restriction 
during pregnancy. Cellular mechanism of organ 
development shows that growth depends on the 
balance between cell proliferation and apoptosis. 
In experimental animal, intrauterine growth 
restriction (IUGR) is associated with increased 
apoptosis of kidney.
The neonates of rats that were born from 
mothers with low protein intake during pregnancy 
have less glomerulus than those whose mothers 
had normal protein intake. Morphological and 
molecular analysis has found that there is an 
increased metanephric apoptosis in IUGR group. 
Apoptosis has a role in normal nephrogenesis.15
Genetic Factors 
In the neonates of rats whose mothers have 
recieved low protein intake during pregnancy, 
there is an increased expressions of several genes 
including genes that code sodium transports 
such as bumetanide-sensitive Na-K-2 Cl co-
transporter (BSC1) and thiazide-sensitive Na-Cl 
co-transporter (TSC). Increased expressions of 
glucocorticoid receptors such as a1 and bI sub-
unit Na-K-ATPase have been found in pregnant 
mothers with protein restriction. These genes will 
increase sodium and water reabsorption, which 
have roles in the pathogenesis of hypertension.11
Hyperactivity of Sympathetic Nerves
It has been known that increased sympathetic 
activity has a role in pathomechanism of 
hypertension. In LBW, increased heart rate and 
reduced heart rate variability during sleep has 
been found compared to infants with normal birth 
weight, which indicate impairment of autonomic 
nerve activity. In adult life, infants with LBW also 
show increased resting pulse rate. This condition 
has been demonstrated by an experimental 
animal study using rats model of placenta 
insuficiency. Kidney denervation in rat neonates 
prevents the development of hypertension. 
Increased sympathetic activity may affect the 
pressure natriuresis and vasoconstriction, which 
result in increased blood pressure.1
Endothelial Dysfunction 
Endothelial dysfunction has an important role 
in the pathomechanism of cardiovascular diseases 
including hypertension. In LBW, endothelial 
dysfunction occurs, which in various studies is 
demonstrated by the presence of impaired flow-
medicated dilatation. Endothelial dysfunction 
causes disturbed vascular remodeling, increased 
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vascular reactivity and inflammatory activity, in 
which those processes have been known to have 
roles in the development of hypertension and 
atherosclerosis. Endothelial dysfunction in LBW 
is caused by reduced expression and activity 
of endothelial nitric oxide synthase (eNOS), 
reduced substrate availability for NO production 
and increased oxidative stress.11
The Role of Elastin
One of factors, which are assumed to have 
role on the correlation between LBW and 
hypertension include the amount and proportion 
and elastin of blood vessels. Elastin is a polymer 
protein with high molecular weight located in the 
aorta with a function to regulate the elasticity 
of blood vessels, both vasoconstriction and 
vasodilatation. Elastin turnover has a half-life 
time of approximately 40 years. With increasing 
age, the amount of elastin is getting less and 
therefore, it causes vascular rigidity. A study has 
demonstrated that the amount of vascular elastin 
is lower in LBW than those who are non-LBW.14
Insulin Resistance
Barker and Hales16 have made a hypothesis, 
which is called the thrifty phenotype. The 
hypothesis suggests that fetal under-nutrition 
causes metabolic and/or physiological adaptation, 
which is aimed to assure nutritional supply to 
vital organs, such as brain by sacrificing the 
less vital organs such as pancreas. Adaptation 
that occurs during the critical periods may be 
permanent, such as reduced pancreatic b-cells 
and insulin skeletal receptors, which later can 
develop insulin resistance. It has been known that 
insulin resistance has a role in pathomechanism 
of hypertension through some effects such as 
stimulation of sympathetic nerves and sodium 
retention.
STUDIES ON HYPERTENSION IN LBW 
The incidence of hypertension due to LBW is 
associtated with birth weight of the born infants. 
A study of 8,760 males and females in Finland 
shows that 1,404 of them have hypertension 
treatment during their adulthood. The incidence 
of hypertension is 20.2% in those who have 
birth weight of up to 3 kg; 16.7% in those who 
have birth weight up to 3.5 kg, 13.6% in those 
with birth weight up to 4 kg and 12.3% in those 
with birth weight over 4 kg. Age affects the 
incidence of hypertension in LBW.5 American 
Nurses Study shows that in LBW, the incidence 
of hypertension is 3% in young age and it is 
increased to 8.5% in older age.1
A meta-analysis of 80 studies shows that 
there is lower systolic blood pressure of 
approximately 2 mmHg for each increase of 1 kg 
birth weight. Another study has found that every 
increase of 1 kg birth body weight is associated 
with a decrease of 2-3 mmHg blood pressure in 
children and teenagers; and a decrease of 2-4 
mmHg in adults.3
The Enigma Study by Miles et al.18 involves 
882 participants in England to evaluate the 
correlation between birth weight, blood pressure, 
arterial stiffness and pulse reflection. The study 
has found that in male with LBW, there are high 
brachial SBP (p=0.04) and central pulse rate 
(p=0.03). Mu et al.19 conducted a meta-analysis 
study of 27 studies to evaluate the correlation 
between birth weight and the development 
of hypertension. They have found that LBW 
(<2500 gram) is associated with increased risk 
of hypertension compared to those with birth 
weight of >2500 gram (OR 1.2; 95% CI, 1.13, 
1.30). When LBW (<2500 gram) is compared to 
birth weight of >2500 gram, there is an increase 
of mean SBP as many as 2.28 mmHg (95% CI 
1.24; 3.33). The result indicates that there is an 
inverse linear correlation between birth weight 
and the risk of hypertension and the correlation 
is particularly obvious on SBP increase.
However, there is a study with different result, 
the study by Chiolero et al.20, that performed an 
analysis on three cohort studies involving 1004 
subjects aged 5.5–9.1 years, 1886 subjects aged 
9.1– 12.5 years and 1575 children aged 12.5-15.5 
years in Syechelles, Africa. The study concludes 
that changes in body weight regardless of the 
age since childbirth have an important role on 
blood pressure in childhood and teenagers, in 
which blood pressure gives greater response on 
the current changes of body weight compared to 
changes of body weight before birth.
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CONCLUSION
Low birth weight is a risk factor for 
cardiovascular and metabolic disorder in 
adulthood. Epidemiological studies indicate 
that there is a correlation between LBW and 
hypertension in adulthood. The pathomechanism 
that links LBW and hypertension is multifactorial 
including delayed nephrogenesis, genetic factors, 
sympathetic hyperactivity, endothel dysfunction, 
elastin deficiencies, insulin resistance and 
activation of renin-angiotension system.
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